论文部分内容阅读
目的:研究利用CT导向下射频消融法进行晚期实体肺癌的治疗的临床表现、病理分析、治疗手段以及预后的影响因素。方法:在半年后回顾经CT导向的射频治疗的肺癌患者的恢复情况,统计其原发性肺癌患者的人数,术后肺癌转移的人数以及评价其治疗的效率和1年内的进展生存期的情况。结果:本组46例病例在接受了共33次的射频治疗后,手术均顺利完成。46例病患的随访时间为12～31个月,平均随访时间为18.3个月,对肿瘤的局部控制率在3、6、12个月后分别为97.2%、92.7%及87.1%,在一年内无进展的生产率为74.3%,无其他并发症产生。结论:进行了CT导向射频治疗的肺癌晚期病患,其肿瘤的形态有减少的趋势,肿瘤的增长速度能够得到有效的抑制。射频消融治疗技术与放疗的结合对于晚期的肺癌患者的治疗而言是一种安全、稳定、有效的方式。
Objective: To study the clinical manifestations, pathological analysis, treatment and prognostic factors of CT-guided radiofrequency ablation in the treatment of advanced solid lung cancer. Methods: Six months later, we reviewed the recovery of patients with lung cancer undergoing CT-guided radiofrequency ablation. The number of patients with primary lung cancer, the number of patients with lung cancer after surgery, and the assessment of the efficiency of treatment and the 1-year progression-free survival . Results: The group of 46 patients received a total of 33 RF radiosurgery, the surgery was successfully completed. 46 patients were followed up for 12 to 31 months, with an average follow-up time of 18.3 months. The local control rate of tumors was 97.2%, 92.7% and 87.1% after 3, 6 and 12 months respectively. No progress in the year of production was 74.3%, no other complications. Conclusion: CT-guided radiofrequency ablation of advanced lung cancer patients, the trend of reducing the trend of the tumor, the tumor growth rate can be effectively inhibited. The combination of radiofrequency ablation and radiotherapy is a safe, stable and effective way for the treatment of advanced lung cancer patients.